Citigroup Inc. Sells 16,490 Shares of Amedisys, Inc. (NASDAQ:AMED)

Citigroup Inc. cut its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 8.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 178,454 shares of the health services provider's stock after selling 16,490 shares during the quarter. Citigroup Inc. owned approximately 0.54% of Amedisys worth $16,530,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of AMED. Hexagon Capital Partners LLC raised its holdings in Amedisys by 108.1% in the 1st quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock worth $29,000 after purchasing an additional 161 shares during the period. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Amedisys by 56.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock worth $31,000 after acquiring an additional 120 shares during the last quarter. Fifth Third Bancorp lifted its stake in shares of Amedisys by 68.1% in the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 141 shares during the last quarter. UMB Bank n.a. boosted its holdings in Amedisys by 100.0% in the first quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock valued at $36,000 after purchasing an additional 193 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in Amedisys during the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 94.36% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen downgraded Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th.

Amedisys Stock Performance

Shares of Amedisys stock traded up $0.03 during trading on Friday, reaching $101.01. The company's stock had a trading volume of 1,060,057 shares, compared to its average volume of 780,222. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.36 and a current ratio of 1.36. The business's fifty day moving average price is $98.02 and its 200-day moving average price is $94.74. The firm has a market cap of $3.32 billion, a price-to-earnings ratio of 39.30, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89. Amedisys, Inc. has a one year low of $82.15 and a one year high of $101.02.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. The company had revenue of $621.86 million for the quarter, compared to analysts' expectations of $614.61 million. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. Amedisys's quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.98 EPS. As a group, equities research analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.